Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations.

Horton, Daniel B; Blum, Michael D; Burcu, Mehmet

Horton, Daniel B; Blum, Michael D; Burcu, Mehmet.

Affiliation

Horton DB; Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ. Electronic address: daniel.horton@rutgers.edu.
Blum MD; Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Burcu M; Department of Epidemiology, Merck & Co., Inc., Kenilworth, NJ.

J Pediatr ; 238: 312-316, 2021 Nov.

Article in En | MEDLINE | ID: mdl-34217767

Subject(s)

Evidence-Based Practice/legislation & jurisprudence; Patient Selection; Randomized Controlled Trials as Topic/legislation & jurisprudence; Treatment Outcome; Age Factors; Child; Europe; Humans; United States

Key words

administrative claims data; electronic health records; observational research; pediatric; pharmacoepidemiology; real-world data

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Treatment Outcome / Patient Selection / Evidence-Based Practice Type of study: Clinical_trials / Prognostic_studies Limits: Child / Humans Country/Region as subject: America do norte / Europa Language: En Journal: J Pediatr Year: 2021 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google